Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
第一作者:
Payam,Tabarsi
第一单位:
Mycobacteriology Research Center, NRITLD, Shaheed Beheshti University of Medical Science, Tehran, Iran. tabarsi@nritld.ac.ir
作者:
主题词
成年人(Adult);丁胺卡那霉素(Amikacin);抗菌药(Anti-Bacterial Agents);临床方案(Clinical Protocols);环丝氨酸(Cycloserine);抗药性, 多种, 细菌(Drug Resistance, Multiple, Bacterial);药物疗法, 联合(Drug Therapy, Combination);广泛耐药结核(Extensively Drug-Resistant Tuberculosis);女(雌)性(Female);人类(Humans);伊朗(Iran);男(雄)性(Male);微生物敏感性试验(Microbial Sensitivity Tests);结核分枝杆菌(Mycobacterium tuberculosis);氧氟沙星(Ofloxacin);丙硫异烟胺(Prothionamide);治疗结果(Treatment Outcome);结核, 肺(Tuberculosis, Pulmonary)
DOI
10.1089/mdr.2009.0073
PMID
20192820
发布时间
2013-11-21
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文